Lucas Goldfarb

408 total citations
10 papers, 297 citations indexed

About

Lucas Goldfarb is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Neurology. According to data from OpenAlex, Lucas Goldfarb has authored 10 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 3 papers in Neurology. Recurrent topics in Lucas Goldfarb's work include Cancer Immunotherapy and Biomarkers (5 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Lung Cancer Diagnosis and Treatment (2 papers). Lucas Goldfarb is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Lung Cancer Diagnosis and Treatment (2 papers). Lucas Goldfarb collaborates with scholars based in France, Switzerland and Spain. Lucas Goldfarb's co-authors include Boris Duchemann, Michaël Soussan, Laurent Zelek, Kader Chouahnia, Florent L. Besson, Laurence Champion, Pierre Véra, Mathieu Salaün, C. Chouaïd and S. Thureau and has published in prestigious journals such as International Journal of Molecular Sciences, Cancers and OncoImmunology.

In The Last Decade

Lucas Goldfarb

10 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lucas Goldfarb France 7 187 154 97 22 22 10 297
Angela Botticella France 11 274 1.5× 75 0.5× 244 2.5× 26 1.2× 33 1.5× 37 405
Grillo Ruggieri F Italy 11 123 0.7× 118 0.8× 145 1.5× 20 0.9× 19 0.9× 33 334
Wichit Arpornwirat Thailand 9 176 0.9× 58 0.4× 71 0.7× 21 1.0× 13 0.6× 17 279
Eren Celik Germany 11 128 0.7× 68 0.4× 112 1.2× 55 2.5× 32 1.5× 25 270
Norimitsu Kasahara Japan 10 196 1.0× 34 0.2× 163 1.7× 8 0.4× 26 1.2× 29 301
Miho Kawashima Japan 9 54 0.3× 107 0.7× 113 1.2× 19 0.9× 8 0.4× 33 293
Xiaoyi Duan China 12 128 0.7× 99 0.6× 104 1.1× 9 0.4× 65 3.0× 31 371
Stephanie Sutherland United Kingdom 9 203 1.1× 84 0.5× 162 1.7× 45 2.0× 12 0.5× 17 379
Kathryn Banfill United Kingdom 9 73 0.4× 241 1.6× 295 3.0× 12 0.5× 14 0.6× 35 504
Marcelle Goldner Cesca Brazil 6 223 1.2× 88 0.6× 76 0.8× 12 0.5× 6 0.3× 18 272

Countries citing papers authored by Lucas Goldfarb

Since Specialization
Citations

This map shows the geographic impact of Lucas Goldfarb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucas Goldfarb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucas Goldfarb more than expected).

Fields of papers citing papers by Lucas Goldfarb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucas Goldfarb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucas Goldfarb. The network helps show where Lucas Goldfarb may publish in the future.

Co-authorship network of co-authors of Lucas Goldfarb

This figure shows the co-authorship network connecting the top 25 collaborators of Lucas Goldfarb. A scholar is included among the top collaborators of Lucas Goldfarb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucas Goldfarb. Lucas Goldfarb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Chawki, Mohammad B., Lucas Goldfarb, Vincent Brulon, et al.. (2023). Relevance of 18F-DOPA visual and semi-quantitative PET metrics for the diagnostic of Parkinson disease in clinical practice: a machine learning-based inference study. EJNMMI Research. 13(1). 6 indexed citations
2.
Goldfarb, Lucas, Mohammad B. Chawki, J. Blin, et al.. (2022). Head-to-Head Comparison Between Rabbit Sign and EANM/SNMMI Criteria for the 18F-DOPA Visual Assessment of Parkinsonian Syndromes in PET/MRI. Clinical Nuclear Medicine. 48(2). 112–118. 1 indexed citations
3.
Goldfarb, Lucas, et al.. (2021). PET Molecular Imaging: A Holistic Review of Current Practice and Emerging Perspectives for Diagnosis, Therapeutic Evaluation and Prognosis in Clinical Oncology. International Journal of Molecular Sciences. 22(8). 4159–4159. 57 indexed citations
4.
Seban, Romain‐David, Jean‐Baptiste Assié, Etienne Giroux‐Leprieur, et al.. (2020). Association of the Metabolic Score Using Baseline FDG-PET/CT and dNLR with Immunotherapy Outcomes in Advanced NSCLC Patients Treated with First-Line Pembrolizumab. Cancers. 12(8). 2234–2234. 26 indexed citations
5.
Seban, Romain‐David, Jean‐Baptiste Assié, Etienne Giroux‐Leprieur, et al.. (2020). FDG-PET biomarkers associated with long-term benefit from first-line immunotherapy in patients with advanced non-small cell lung cancer. Annals of Nuclear Medicine. 34(12). 968–974. 25 indexed citations
6.
Goldfarb, Lucas, Boris Duchemann, Kader Chouahnia, Laurent Zelek, & Michaël Soussan. (2019). Monitoring anti-PD-1-based immunotherapy in non-small cell lung cancer with FDG PET: introduction of iPERCIST. EJNMMI Research. 9(1). 8–8. 115 indexed citations
7.
Bohelay, G., Lucas Goldfarb, Vincent Barrau, et al.. (2019). Late onset of nivolumab-induced severe gastroduodenitis and cholangitis in a patient with stage IV melanoma. Immunotherapy. 11(12). 1005–1013. 23 indexed citations
8.
Goldfarb, Lucas, Stéphanie Becker, Isabelle Gardin, et al.. (2019). Sub-cutaneous Fat Mass measured on multislice computed tomography of pretreatment PET/CT is a prognostic factor of stage IV non-small cell lung cancer treated by nivolumab. OncoImmunology. 8(5). e1580128–e1580128. 42 indexed citations
9.
Goldfarb, Lucas, et al.. (2017). Étude préliminaire sur les effets de la chimiothérapie sur le métabolisme cérébral des patients traités pour un lymphome de Hodgkin. Médecine Nucléaire. 41(3). 185–185. 1 indexed citations
10.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angela Botticella Breakdown of academic impact, for papers by Grillo Ruggieri F Breakdown of academic impact, for papers by Wichit Arpornwirat Breakdown of academic impact, for papers by Eren Celik Breakdown of academic impact, for papers by Norimitsu Kasahara Breakdown of academic impact, for papers by Miho Kawashima Breakdown of academic impact, for papers by Xiaoyi Duan Breakdown of academic impact, for papers by Stephanie Sutherland Breakdown of academic impact, for papers by Kathryn Banfill Breakdown of academic impact, for papers by Marcelle Goldner Cesca
Rankless by CCL
2026